388 related articles for article (PubMed ID: 28376901)
1. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
2. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
Tan J; Qiu K; Li M; Liang Y
FEBS Lett; 2015 Oct; 589(20 Pt B):3175-81. PubMed ID: 26318860
[TBL] [Abstract][Full Text] [Related]
3. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
5. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Apr; 107(5):555-9. PubMed ID: 22961206
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA TUG1 Enhances Radiosensitivity of Prostate Cancer via the TUG1/miR-139-5p/SMC1A Axis.
Xiu D; Liu L; Cheng M; Sun X; Ma X
Onco Targets Ther; 2020; 13():2319-2331. PubMed ID: 32256083
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA TUG1 attenuates inflammation and apoptosis of renal tubular epithelial cell induced by ischemia-reperfusion by sponging miR-449b-5p via targeting HMGB1 and MMP2.
Xu Y; Niu Y; Li H; Pan G
Inflammation; 2020 Aug; 43(4):1362-1374. PubMed ID: 32206944
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.
Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K
Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
Cai H; Liu X; Zheng J; Xue Y; Ma J; Li Z; Xi Z; Li Z; Bao M; Liu Y
Oncogene; 2017 Jan; 36(3):318-331. PubMed ID: 27345398
[TBL] [Abstract][Full Text] [Related]
16. Structural maintenance of chromosomes 2 is identified as an oncogene in bladder cancer in vitro and in vivo.
Han YH; Wan Y; Xiong H; Sun GL
Neoplasma; 2020 Mar; 67(2):364-370. PubMed ID: 31986889
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1.
Shan G; Tang T; Xia Y; Qian HJ
Biomed Pharmacother; 2020 Jan; 121():109248. PubMed ID: 31734579
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]